Surgical Procedure Sample Clauses

Surgical Procedure. This is a: • A cutting procedure; • Suturing of a wound; • Treatment of a fracture; • Reduction of a dislocation; • Radiotherapy (excluding radioactive isotope therapy), if used in lieu of a cutting operation for removal of a tumor; • Electrocauterization; • Diagnostic and therapeutic endoscopic procedures; • Injection treatment of hemorrhoids and varicose veins; • An operation by means of laser beam; • Cryosurgery.
AutoNDA by SimpleDocs
Surgical Procedure. The multi-disciplinary heart team decided on the indication and timing of surgery. SVR was performed if it was likely that a postoperative end-systolic volume index of 70 ml/m2 or less was achieved in a heart failure patient with a postinfarction left ventricular aneurysm.14 The procedure was performed according to the technique described by Dor.15 All operations were performed using cardiopulmonary bypass, aortic cross-clamping and intermittent warm blood cardioplegia. Patients received an arterial line and a pulmonary artery catheter for intra- and postoperative 4 monitoring. These data were used to calculate CI. Intraoperatively, a mean arterial pressure (MAP) ≤65 mmHg was corrected using norepinephrine. Postoperatively, norepinephrine was started if the MAP was ≤65 mmHg and the CI was normal (after adequate administration of intravascular fluids if necessary), aiming for a MAP >65mmHg and adequate end-organ perfusion. When a norepinephrine dosage >1 µg/kg/min was required, terlipressin was started. Statistical analysis Continuous variables are expressed as mean ± standard deviation (SD) when normally distributed, or otherwise as median and interquartile range (IQR). Categorical variables are presented percentages. Missing values (NT-ProBNP baseline (N=37); thyroxine baseline (N=36); creatinine clearance 6 months (N=18), 12 months (N=19) and 24 months (N=12) follow up; NYHA 24 months (N=3) follow up; LVEF 24 months (N=3)), were replaced using multiple imputation with predictive mean matching, which was repeated a hundred times. Baseline age, gender, EuroSCORE, NYHA class, creatinine clearance and follow up data of NYHA and creatinine clearance were used as predictors in the model. The pooled data was used for analysis. Vasoplegic and non-vasoplegic patients were compared. Comparison of continuous data was performed using two-tailed unpaired Student t test for normally distributed variables or otherwise the Xxxx-Xxxxxxx U test. Comparison of categorical variables was performed using the Xxxxxx’x exact test. The Xxxxxx Xxxxx method was used to assess 6-month and 2-year mortality in vasoplegic and non-vasoplegic patients. Landmark analysis was used to assess the late effect of vasoplegia on mortality between 6 months and 2-years postoperative. Survival distributions were compared using the log-rank test. Univariable Xxx regression analysis was used to investigate the association between perioperative characteristics and 2-year mortality. The proportional h...
Surgical Procedure. Benefits for the surgical procedure include surgical services required for the treatment of a disease or injury when performed by a Physician or other Professional Provider on a Member in an Inpatient Hospital or Outpatient setting. Certain rules and guidelines apply if an additional surgeon or multiple surgeries are needed.
Surgical Procedure. The Mini-Gastric Bypass: I understand that the procedure that my surgeon has recommended is the Mini- Gastric Bypass. My surgeon with the help and assistance of the staff of The Centers for Laparoscopic Obesity Surgery, my doctor, my family and many patients that have undergone Mini-Gastric Bypass have provided me with a detailed explanation of the medical history of the development of the surgical treatment of obesity, gastric surgery as a treatment of obesity, the development of laparoscopic (minimally invasive) surgery and the Mini- Gastric Bypass. I have been provided with drawings, photographs, written and verbal descriptions of the operation and other alternative surgeries including the "Sleeve" Gastrectomy, Open Roux-en-Y Gastric Bypass, Laparoscopic Roux-en-Y Gastric Bypass, Slapstick Ring Vertical Gastric Bypass (Fobi Pouch), Micro pouch Gastric Bypass, Antecolic Laparoscopic Roux-en-Y Gastric Bypass, Long Limb Gastric Bypass, Biliopancreatic Diversion, Biliopancreatic Diversion with Duodenal Switch, Gastric Band, Laparoscopic Gastric Band, Laparoscopic Adjustable Gastric Band, Vertical Banded Gastroplasty, Laparoscopic Vertical Banded Gastroplasty and others. I have talked with patients that have previously undergone the Mini-Gastric Bypass surgery. I have made every reasonable effort to investigate and understand the details of the operation. I believe that my surgeon and the staff of CLOS have gone beyond what many other doctors do to inform me of the risks and benefits of the surgery and to assist me in making a good decision about obesity and surgery for obesity. If you agree that, everything in the above paragraph is correct, check Yes Here: † Initial the paragraph above Write a description of the previous paragraph and comments (More than two sentences): Medical Controversy I affirm here unequivocally and without reservations that I understand that medical care often involves major controversy. I clearly recognize that weight loss surgery now is filled with controversy: sleeve gastrectomy, gastric banding types of surgery vs. bypass types of surgery, proximal gastric bypasses vs. distal gastric bypasses, bypass type surgery vs. the duodenal switch vs. the Fobi pouch and the new Adjustable Gastric Band. The list of disagreements about whether to have surgery and what kind of surgery is best is extensive. I understand that there are many different types and variations in the surgical procedures being performed for weight loss in America and a...
Surgical Procedure. Ancillary Only 1.75 13 Surgical Procedure w/o Ancillary – Room Only 3.75 14 Surgical Procedure w/o Ancillary – MD & Room 7.50 15 Surgical Procedure w/ Ancillary – Room Only 5.50 16 Surgical Procedure w/ Ancillary – MD & Room 9.25 18 Inpatient Points Contracting Hospital 19 Acute Days 15 20 Critical Days (including Burn Days) 40 21 Acute & Telemetry (step-down) 20 22 Nursing Care DayLevel Two 8 23 Nursing Care Day – Level One 6.5 24 Admin Days 6 25 26 Trauma Points 27 Died in E.R. 32 28 Died in O.R. 149 29 Admitted 38
Surgical Procedure. Each patient will undergo bilateral STN-DBS implantation, which will take place entirely within the MR suite. Implantation will follow the general methodology outlined in Section 2.3.1, but will be performed with the delivery system validated in Section 3.1. The patient will be anesthetized and immobilized in the RF coil. Surface grids will be placed bilaterally on the skull and the patient moved into the magnet bore. MR contrast (Magnevist, Bayer HealthCare) will be administered and a volumetric T1-weighted MR scan will be performed to reveal brain structure and vessel location. Standard offsets for the STN target (3mm posterior, 12mm lateral and 4 mm inferior to mid-point of AC-PC) will be assumed and possible trajectories will be explored. Once an acceptable trajectory is identified, the exit coordinates on the external grid will be identified and a xxxx will be made on the skull with a punch tool. This procedure will be repeated for the contralateral side. The patient will then be moved to the rear magnet opening and a sterile field established. Skin incisions and burrholes will be created at the marked sites and the exposed dura mater opened. Finally, the trajectory guides will be mounted and the remote actuator systems attached. The patient will be returned to magnet isocenter and high quality T2-weighted images will be acquired in an oblique axial plane parallel to AC-PC. Bilateral targets within the dorsolateral STN will be identified in this dataset by an attending neurosurgeon (PS or PL). MR scanning will additionally be performed on the trajectory guides to identify the point around which they articulate (pivot point), the orientation of the base with respect to the patient’s anatomy, and the initial orientation of the alignment indicator. Trajectory guide alignment and mandrel insertion will be performed serially, with acceptable mandrel positioning achieved on one side before continuing to the contralateral side. Fluoroscopic MR imaging through the distal aspect of the trajectory guide will be run while the surgeon remotely manipulates the trajectory guide. Real-time feedback showing an automatically generated ray projection from the trajectory guide onto the image slice that the target was identified on will be presented to the surgeon on the in-room monitor. Once this projection intersects the identified target, the fluoroscopic sequence will be interrupted and two orthogonal MR images along the desired trajectory acquired. The orientation o...
Surgical Procedure. Ancillary Only 1.75 Surgical Procedure w/o Ancillary – Room Only 3.75 Surgical Procedure w/o Ancillary – MD & Room 7.50 Surgical Procedure w/ Ancillary – Room Only 5.50 Surgical Procedure w/ Ancillary – MD & Room 9.25 Inpatient Categories Acute Days 15.00 Critical Days (including Burn Days) 40.00 Acute & Telemetry (step-down) 20.00 Nursing Care Day – Level Two 8.00 Nursing Care Day – Level One 6.50 Admin Days 6.00 Trauma Categories Died in E.R 32.00 Died in O.R 149.00 Admitted 38.00 Other Categories Recuperative Care Day 2.00 1 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20
AutoNDA by SimpleDocs

Related to Surgical Procedure

  • General Procedure (a) At each Closing, and effective as of each Closing Date, each party shall deliver to the party entitled to receipt thereof the documents required to be delivered pursuant to Article VII and such other documents, instruments and materials (or complete and accurate copies thereof, where appropriate) as may be reasonably required in order to effectuate the intent and provisions of this Agreement, including the applicable Appendix D, and all such documents, instruments and materials shall be satisfactory in form and substance to counsel for the receiving party.

  • OPERATIONAL PROCEDURES In order to minimize operational problems, it will be necessary for trade information to be supplied in a secure manner by the Subadviser to the Fund’s Service Providers, including: JPMorgan Chase Bank, National Association (the “Custodian”), Virtus Fund Services (the “Fund Administrator”) BNY Mellon Investment Servicing (US) Inc., (the “Sub-Accounting Agent”), any Prime Broker to the Series, and all other Counterparties/Brokers as required. The Subadviser must furnish the Fund’s service providers with required daily information as to executed trades in a format and time-frame agreed to by the Subadviser, Custodian, Fund Administrator, Sub-Accounting Agent and Prime Broker/Counterparties and designated persons of the Fund. Trade information sent to the Custodian, Fund Administrator, Sub-Accounting Agent and Prime Broker/Counterparties must include all necessary data within the required timeframes to allow such parties to perform their obligations to the Series. The Sub-Accounting Agent specifically requires a daily trade blotter with a summary of all trades, in addition to trade feeds, including, if no trades are executed, a report to that effect. Daily information as to executed trades for same-day settlement and future trades must be sent to the Sub-Accounting Agent no later than 4:30 p.m. (Eastern Time) on the day of the trade each day the Fund is open for business. All other executed trades must be delivered to the Sub-Accounting Agent on Trade Date plus 1 by Noon (Eastern Time) to ensure that they are part of the Series’ NAV calculation. (The Subadviser will be responsible for reimbursement to the Fund for any loss caused by the Subadviser’s failure to comply with the requirements of this Schedule A.) On fiscal quarter ends and calendar quarter ends, all trades must be delivered to the Sub-Accounting Agent by 4:30 p.m. (Eastern Time) for inclusion in the financial statements of the Series. The data to be sent to the Sub-Accounting Agent and/or Fund Administrator will be as agreed by the Subadviser, Fund Administrator, Sub-Accounting Agent and designated persons of the Fund and shall include (without limitation) the following:

  • GRIEVANCE PROCEDURE 7.01 For purposes of this Agreement, a grievance is defined as a difference arising between the parties relating to the interpretation, application, administration or alleged violation of the Agreement including any question as to whether a matter is arbitrable.

  • General Procedures If at any time on or after the date the Company consummates a Business Combination the Company is required to effect the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as expeditiously as possible:

  • Sale Procedure 24 21.2 Application of Proceeds of Sale...............................26 21.3

  • Dispute Resolution Process Any claim, dispute or other matter in question not resolved by the process identified in Paragraph

  • AML Procedures1 4.1 Consistent with the services provided by DST and with respect to the ownership of Shares in the Fund for which DST maintains the applicable Fund shareholder information, DST shall:

  • Dispute Resolution Procedure 21.1 All disputes or grievances arising between the Parties shall as far as practical be resolved at the workplace level through consultation. Accordingly the following procedure must be followed:

  • Exclusive Dispute Resolution Mechanism The Parties agree that the procedures set forth in this Article 12 shall be the exclusive mechanism for resolving any dispute, controversy, or claim (collectively, “Disputes”) between the Parties that may arise from time to time pursuant to this Agreement relating to any Party’s rights and/or obligations hereunder that cannot be resolved through good faith negotiation between the Parties.

  • Dispute Resolution Procedures (a) In the event a dispute arises about the interpretation, application, calculation of Loss, or calculation of payments or otherwise with respect to this Single Family Shared-Loss Agreement (“SF Shared-Loss Dispute Item”), then the Receiver and the Assuming Institution shall make every attempt in good faith to resolve such items within sixty (60) days following the receipt of a written description of the SF Shared-Loss Dispute Item, with notification of the possibility of taking the matter to arbitration (the date on which such 60-day period expires, or any extension of such period as the parties hereto may mutually agree to in writing, herein called the “Resolution Deadline Date”). If the Receiver and the Assuming Institution resolve all such items to their mutual satisfaction by the Resolution Deadline Date, then within thirty (30) days following such resolution, any payment due as a result of such resolution shall be made arising from the settlement of the SF Shared-Loss Dispute.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!